Skip to main content
. 2016 Feb 8;16(4):1–79.

Table A2:

Risk of Bias Among Randomized Controlled Trials for the Comparison of Mechanical Thrombectomy and Clinical Outcomes

Author, Year Allocation Concealments Blindingb Complete Accounting of Patients and Outcome Events Selective Reporting Bias Other Limitationsc
Berkhemer et al, 201527 No limitations No limitations No limitations Limitationsd No limitations
Campbell et al, 201528 No limitations No limitations No limitations No limitations Limitationse
Goyal et al, 201529 No limitations No limitations No limitations Limitationsd Limitationse
Jovin et al, 201530 No limitations No limitations No limitations No limitations Limitationse
Saver et al, 201531 No limitations No limitations No limitations No limitations Limitationse

Abbreviations: RCT, randomized controlled trial.

a

All five RCTs used a web-based randomized minimization procedure.

b

All five included RCTs had blind outcome evaluation, but physicians conducting the intervention were aware of treatment assignment. This was appropriate, as a sham procedure was not ethical, and the standard of care is intravenous thrombolysis, which is a more appropriate comparator.

c

All five studies had grant support from Covidien/ev3 (the company that manufactures the Solitaire FR stent retriever) and/or other manufacturers/industry support.

d

Protocol states the functional outcome measured by the Academic Linear Disability Scale would be collected at 90 days, but this outcome was not reported in the published article.

e

After the Berkhemer et al (28) study was published, the four following RCTs stopped early based on prespecified boundaries for efficacy during interim analysis.

f

Protocol states the functional outcome measured by miFUNCTION scale would be collected, but this outcome was not reported in the published article.